Design of phase II, randomized, placebo-controlled study of loratadine associate with rapamycin in patients with lymphangioleiomyomatosis (LAM)
Jaume Bordas-Martínez, Carmen Herranz, Vanesa Vicens-Zygmunt, Antonio Román, Cristina Berastegui, Piedad Ussetti, Rosalía Laporta, Julio Ancochea, Claudia Valenzuela, Alvaro Casanova, Emilio Ansótegui, Jose Antonio Rodríguez-Portal, Guadalupe Bermudo, Patricio Luburich, Roger Llatjós, Salud Santos, Jordi Dorca, Pilar Hereu, Miquel Àngel Pujana * Sharing Senior Position, Maria Molina-Molina * Sharing Senior Position
European Respiratory Journal Sep 2020, 56 (suppl 64) 3401; DOI: 10.1183/13993003.congress-2020.3401